rs66876876

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_199037.5(SCN1B):​c.641G>A​(p.Arg214Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00306 in 1,559,664 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R214W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0022 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0032 ( 8 hom. )

Consequence

SCN1B
NM_199037.5 missense

Scores

14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:8B:12O:1

Conservation

PhyloP100: -0.828

Publications

32 publications found
Variant links:
Genes affected
SCN1B (HGNC:10586): (sodium voltage-gated channel beta subunit 1) Voltage-gated sodium channels are heteromeric proteins that function in the generation and propagation of action potentials in muscle and neuronal cells. They are composed of one alpha and two beta subunits, where the alpha subunit provides channel activity and the beta-1 subunit modulates the kinetics of channel inactivation. This gene encodes a sodium channel beta-1 subunit. Mutations in this gene result in generalized epilepsy with febrile seizures plus, Brugada syndrome 5, and defects in cardiac conduction. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009]
HPN-AS1 (HGNC:47041): (HPN antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005021572).
BP6
Variant 19-35033932-G-A is Benign according to our data. Variant chr19-35033932-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 190847.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00219 (334/152296) while in subpopulation NFE AF = 0.00382 (260/68026). AF 95% confidence interval is 0.00344. There are 1 homozygotes in GnomAd4. There are 149 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 8 AD,Unknown,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_199037.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN1B
NM_001037.5
MANE Select
c.448+193G>A
intron
N/ANP_001028.1Q07699-1
SCN1B
NM_199037.5
c.641G>Ap.Arg214Gln
missense
Exon 3 of 3NP_950238.1Q07699-2
SCN1B
NM_001321605.2
c.349+193G>A
intron
N/ANP_001308534.1A0A1W2PR05

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN1B
ENST00000415950.5
TSL:1
c.641G>Ap.Arg214Gln
missense
Exon 3 of 3ENSP00000396915.2Q07699-2
SCN1B
ENST00000262631.11
TSL:1 MANE Select
c.448+193G>A
intron
N/AENSP00000262631.3Q07699-1
SCN1B
ENST00000638536.1
TSL:1
c.448+193G>A
intron
N/AENSP00000492022.1Q07699-1

Frequencies

GnomAD3 genomes
AF:
0.00219
AC:
334
AN:
152178
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000603
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00264
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00382
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00236
AC:
388
AN:
164114
AF XY:
0.00234
show subpopulations
Gnomad AFR exome
AF:
0.000458
Gnomad AMR exome
AF:
0.000597
Gnomad ASJ exome
AF:
0.000231
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00413
Gnomad NFE exome
AF:
0.00423
Gnomad OTH exome
AF:
0.00306
GnomAD4 exome
AF:
0.00315
AC:
4437
AN:
1407368
Hom.:
8
Cov.:
33
AF XY:
0.00301
AC XY:
2091
AN XY:
695134
show subpopulations
African (AFR)
AF:
0.000470
AC:
15
AN:
31882
American (AMR)
AF:
0.000554
AC:
20
AN:
36126
Ashkenazi Jewish (ASJ)
AF:
0.000435
AC:
11
AN:
25262
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36118
South Asian (SAS)
AF:
0.000521
AC:
42
AN:
80662
European-Finnish (FIN)
AF:
0.00359
AC:
179
AN:
49914
Middle Eastern (MID)
AF:
0.00193
AC:
11
AN:
5700
European-Non Finnish (NFE)
AF:
0.00371
AC:
4015
AN:
1083326
Other (OTH)
AF:
0.00247
AC:
144
AN:
58378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
257
513
770
1026
1283
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
144
288
432
576
720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00219
AC:
334
AN:
152296
Hom.:
1
Cov.:
32
AF XY:
0.00200
AC XY:
149
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.000602
AC:
25
AN:
41562
American (AMR)
AF:
0.000588
AC:
9
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00264
AC:
28
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00382
AC:
260
AN:
68026
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
18
36
55
73
91
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00294
Hom.:
0
Bravo
AF:
0.00222
TwinsUK
AF:
0.00512
AC:
19
ALSPAC
AF:
0.00389
AC:
15
ESP6500AA
AF:
0.000806
AC:
2
ESP6500EA
AF:
0.00469
AC:
21
ExAC
AF:
0.00250
AC:
270

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
6
not provided (9)
-
1
5
not specified (6)
-
1
1
Brugada syndrome 5 (2)
-
1
-
Atrial fibrillation, familial, 13 (1)
-
1
-
Developmental and epileptic encephalopathy, 52 (1)
-
1
-
Generalized epilepsy with febrile seizures plus, type 1 (1)
-
1
-
Long QT syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
1.3
DANN
Benign
0.97
Eigen
Benign
-0.95
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.016
N
LIST_S2
Benign
0.48
T
MetaRNN
Benign
0.0050
T
MetaSVM
Benign
-0.73
T
PhyloP100
-0.83
PrimateAI
Benign
0.17
T
PROVEAN
Benign
0.31
N
REVEL
Benign
0.062
Sift
Benign
0.34
T
Polyphen
0.017
B
Vest4
0.14
MVP
0.79
MPC
0.84
ClinPred
0.0019
T
GERP RS
0.78
gMVP
0.13
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs66876876; hg19: chr19-35524836; COSMIC: COSV99386640; COSMIC: COSV99386640; API